Caregivers of people with Lennox-Gastaut syndrome (LGS) in focus groups most frequently cited knowledge gaps on the part of…
Steve Bryson PhD
Steve holds a PhD in Biochemistry from the Faculty of Medicine at the University of Toronto, Canada. He worked as a medical scientist for 18 years in both industry and academia, where his research focused on discovering new medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson PhD
Two nerve-stimulating devices, vagus nerve stimulation (VNS) and deep brain stimulation (DBS), were associated with similar reductions in seizure frequency…
Cannabidiol (CBD) — the active ingredient in Epidiolex — was found to bind to and block the…
Adding Epidiolex, an oral cannabidiol medication, to other treatments successfully stopped epileptic seizures in a boy with…
The add-on anti-seizure therapy Inovelon (rufinamide) shows good tolerability, with one year of treatment not affecting…
Epidiolex (cannabidiol) treatment led to lithium toxicity in a boy with…
The Scottish Medicines Council (SMC) approved Epidyolex (cannabidiol), combined with the anti-epileptic medicine…
Epidiolex, a cannabidiol add-on medication for treatment-resistant epilepsy, was safely given to children…
A single gene therapy treatment using microRNAs improved growth and development, and decreased lethal seizures in…
Mice created with a single mutation found in a person with Lennox-Gastaut syndrome…